Post-earnings recap
Reported
Thu, Feb 20, 2014
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
63%
Dexcom's earnings report shows a mixed performance, with a smaller-than-expected loss per share. However, the lack of revenue details and no guidance contributed to a negative stock reaction, with shares falling 2.47%. Investors may be cautious as the company navigates current challenges while focusing on long-term growth strategies.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.04 | N/A | +44.44% |
| Revenue | N/A | N/A | N/A |
Management remains focused on innovation and expanding market reach. They acknowledged short-term hurdles but are optimistic about future prospects.
Management highlighted ongoing investments in product development.
They expressed confidence in long-term growth despite current challenges.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—